OTC : MRAI

Marpai, Inc. — News

$2.21 USD

$0.02 (0.91%)

Volume
200
Average Volume
77.56K
Market Capitalization
$55.9M
P/E Ratio
-2.54
Dividend Yield
0.00%
Price Target
$6.00
Year High
$2.50
Year Low
$0.22
Day High
Day Low
Payout Ratio
$0.00
Current Ratio
$0.38
Source Headline
Marpai Announces $12 Million Private Placement led by Mitchell Companies

TAMPA, Fla., July 29, 2026 /PRNewswire/ -- Marpai, Inc. ("Marpai" or the "Company") (OTCQX: MRAI), a leader in innovative healthcare technology, Third-Party Administration ("TPA"), and Pharmacy Benefit Management ("PBM") services, today announced that it entered into securities purchase agreements with accredited investors in a private placement of newly designated convertible preferred stock.

prnewswire.com - 2026-07-29 16:18:00

Marpai Inc. Announces Debt Restructuring Agreements with JGB Capital and AXA, Reducing Debt Service by $26.4 Million Through 2027 and Enhances Near term Liquidity

Debt restructuring aligns capital structure, with projected operational cash flows, and unlocks capital for growth TAMPA, Fla., July 20, 2026 /PRNewswire/ -- Marpai, Inc. ("Marpai" or the "Company") (OTCQX: MRAI), a leader in innovative healthcare technology, Third-Party Administration ("TPA"), and Pharmacy Benefit Management ("PBM") services, today announced that it has entered into debt restructuring agreements with JGB Capital, in May 2026, and AXA S.A.

prnewswire.com - 2026-07-20 08:31:00

Marpai Inc. Announces Unprecedented Growth with 192,000 New Estimated Member Lives Across TPA and MarpaiRx PBM Platforms; Expects to Achieve Positive Cash Flow and EBITDA Beginning August 2026

TAMPA, Fla., May 26, 2026 /PRNewswire/ -- Marpai, Inc. ("Marpai" or the "Company") (OTCQX: MRAI), a leader in innovative healthcare technology, Third-Party Administration ("TPA"), and Pharmacy Benefit Management ("PBM") services, today announced a historic expansion of its business book.

prnewswire.com - 2026-05-26 16:07:00

MARPAI REPORTS FIRST QUARTER 2026 FINANCIAL RESULTS

Strategic Investments in Operations and Technology Fuel Platform for Accelerated Growth and Aim of Second-Half 2026 Profitability TAMPA, Fla., May 15, 2026 /PRNewswire/ -- Marpai, Inc. ("Marpai" or the "Company") (OTCQX: MRAI), a leader in innovative healthcare technology, Third-Party Administration (TPA), and Pharmacy Benefit Management ("PBM") services, announced the financial results for the first quarter 2026.

prnewswire.com - 2026-05-15 16:03:00

Get MRAI Insider Trade Alerts

MRAI Price Target Summary

Last Month

$0.00

0 analysts

Last Quarter

$0.00

0 analysts

Last Year

$0.00

0 analysts

All Time

$6.00

1 analysts

MRAI Recent Analyst Grades

Date Analyst Firm Action Previous Grade New Grade
2024-03-28 Maxim Group Upgrade Hold Buy